CompletedNot Applicable

The Transition From Blastomere to Trophectoderm Biopsy: Comparing Two PGS Strategies

383 participantsStarted 2014-01-01

Plain-language summary

Shortly after the implementation of Comprehensive Chromosome Screening (CCS) techniques for Preimplantation Genetic Screening (PGS) came the transition in biopsy timing. Trophectoderm biopsy is meant to overcome the limitations of cleavage stage biopsy and single cell analysis.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Own gametes * PGS for: advanced maternal age, repeated implantation failure, recurrent miscarriages, severe male factor, and previous affected pregnancies Exclusion Criteria: * PGS cycles with gamete donation * Altered karyotypes * Combined Preimplantation genetic diagnosis (PGD)+PGS cycles

What they're measuring

Ongoing clinical pregnancy rate

Timeframe: 20 weeks after embryo transfer

Trial details

NCT IDNCT03062969

SponsorFundacion Dexeus

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-02-28

View on ClinicalTrials.gov More Infertility trials